Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
Classement en actions #178
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Prix de l'action
$44.60
Capitalisation boursière
$108.62B
Changement (1 jour)
-1.63%
Changement (1 an)
-21.62%
Pays
FR
Échange Sanofi (SNY)

Catégorie

Marge opérationnelle de Sanofi (SNY)
Marge opérationnelle au March 2026 TTM : 25.39%
Selon les derniers rapports financiers et le cours de l'action de Sanofi, la marge opérationnelle actuelle (TTM) est de 25.39%. À la fin de 2024, elle était de 21.47%.
Historique de la marge opérationnelle pour Sanofi de 2000 à 2026
Marge opérationnelle à la fin de chaque année
Année Marge opérationnelle Changez
2026 (TTM) 25.39% -22.28%
2025 32.67% 52.17%
2024 21.47% 25.48%
2023 17.11% -53.76%
2022 37.00% 78.40%
2021 20.74% -4.11%
2020 21.63% 5.77%
2019 20.45% -41.30%
2018 34.84% 5.10%
2017 33.15% -6.80%
2016 35.57% -2.44%
2015 36.46% -7.58%
2014 39.45% -5.12%
2013 41.58% -4.79%
2012 43.67% 167.09%
2011 16.35% -12.14%
2010 18.61% -10.10%
2009 20.70% -38.90%
2008 33.88% 67.39%
2007 20.24% 4.17%
2006 19.43% -25.64%
2005 26.13% -1,593.14%
2004 -1.75% -104.58%
2003 38.21% 8.89%
2002 35.09% 8.10%
2001 32.46% 22.72%
2000 26.45% 0.00%
Marge opérationnelle pour des entreprises similaires ou concurrentes
Entreprise Marge opérationnelle Différence de Marge Opérationnelle Pays
45.56% -98.21%
US
23.28% -99.08%
GB
27.17% -98.93%
US
26.72% -98.95%
US
31.24% -98.77%
CH
Qu'est-ce que la Marge opérationnelle d'une entreprise ?
La Marge opérationnelle est un indicateur clé pour évaluer la rentabilité d'une entreprise. Une marge d'exploitation plus élevée est généralement préférable car elle montre qu'une entreprise peut vendre ses produits ou services bien au-dessus de leurs coûts de production. Elle se calcule en divisant les bénéfices par le chiffre d'affaires.